FDA — authorised 30 December 1980
- Application: NDA017854
- Marketing authorisation holder: ANI PHARMS
- Status: supplemented
FDA authorised Reglan on 30 December 1980
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 30 December 1980; FDA authorised it on 20 December 2013; FDA has authorised it.
ANI PHARMS holds the US marketing authorisation.